New Biotech Company Grows From MCG Diabetes And Genomic Research

A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer. Dr…

No Comments

Pregnancy And Pre-Existing Diabetes

Pregnancy is a time of wonder and amazement — and for women with pre-existing diabetes, it is also a time for very extremely careful (and sometimes baffling) disease management…

No Comments

Unearthing King Tet, Key Protein Influences Stem Cell Fate

Take a skin cell from a patient with Type 1 diabetes. Strip out everything that made it a skin cell, then reprogram it to grow into a colony of pancreatic beta cells. Implant these into your patient and voila! She’s producing her own insulin like a pro. This type of personalized therapy is the ultimate [...]

No Comments

European Union Urged To Take Action On Diabetes And Other Chronic Conditions

A coalition of organisations representing people with chronic conditions is campaigning for the introduction of measures to address poor diet, lack of exercise, excessive use of alcohol and smoking in a bid to improve the health of people across Europe…

No Comments

Master Regulator Discovery In Cell Metabolism, Response To Stress, Could Impact Obesity, Diabetes And Cancer Research

AMP-activated protein kinase, or AMPK, is a master regulator protein of metabolism that is conserved from yeast to humans. When a cell is low on fuel, AMPK shuts down processes that use energy and turns on processes that produce energy…

No Comments

Takeda Responds To FDA Advisory Committee Recommendation

The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular (CV) safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc…

No Comments

Biodel Reports Progress With Development Of Glucose-Regulated ‘Smart’ Basal Insulin

Biodel Inc. (Nasdaq: BIOD) reported results of preclinical tests which demonstrated the potential of the company’s glucose-regulated or “smart” basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions…

No Comments

Researchers Find Dementia In Diabetics Differs From Dementia In Nondiabetics

Researchers from Mayo Clinic’s Florida campus say that dementia in some diabetics appears to be caused often by vascular disease in the brain, and the dementia that develops in people without diabetes is more likely associated with deposition of the plaque seen in people with Alzheimer’s disease…

No Comments

Sernova Announces Positive Results Of Its Proprietary Cell Pouch SystemTM In Preclinical Diabetes Model

Sernova Corp. (TSX VENTURE:SVA) is pleased to report positive results from a long-term study evaluating the safety and efficacy of the Cell Pouch System™ in a pre-clinical model of diabetes…

No Comments

pSivida Announces Submission Of MAA For An Ophthalmic Product For Diabetic Macular Edema In Certain European Union Countries

pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, announced that its licensee, Alimera Sciences (NASDAQ:ALIM) has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®…

No Comments